These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4151910)

  • 1. Cardiovascular effects of dl-1-(2-acetyl-4-butyramido-phenoxy)-2-hydroxy-3-isopropylaminopropane (M & B 17,803A), a new cardioselective beta adrenoreceptor blocking agent.
    Laddu AR
    Jpn Heart J; 1974 Jan; 15(1):72-83. PubMed ID: 4151910
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism of cardiac arrhythmias by dl-1-(2-acetyl-4-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane (M & B 17,803A), a new beta adrenoreceptor blocking agent.
    Laddu AR
    Jpn Heart J; 1974 Jan; 15(1):61-71. PubMed ID: 4151909
    [No Abstract]   [Full Text] [Related]  

  • 3. The selective beta receptor blocking properties of DL-1-(2-acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane HC1 (M & B 17803-A) in the anesthetized dog.
    Levy B
    J Pharmacol Exp Ther; 1973 Jul; 186(1):134-44. PubMed ID: 4146701
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.
    Basil B; Jordan R; Loveless AH; Maxwell DR
    Br J Pharmacol; 1973 Jun; 48(2):198-211. PubMed ID: 4147427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of selective beta-adrenoceptor blockade in man.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1973 Sep; 49(1):106-14. PubMed ID: 4150760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoproterenol blockade in man; comparison between penbutalol and acebutolol.
    Coleman AJ; Leary WP; Asmal AC
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):64-79. PubMed ID: 4149207
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of two cardioselective beta-adrenergic blocking agents: effects on haemodynamic and atrioventricular conduction in man.
    Crouchman M
    Br Heart J; 1973 Aug; 35(8):865. PubMed ID: 4147117
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of acute effects of hydralazine by an adrenergic beta-receptor blocking agent.
    Brunner H; Hedwall PR; Meier M
    Experientia; 1965 Mar; 21(3):136-7. PubMed ID: 4378541
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of propranolol and a new 'cardioselective' beta-blocker, H 93-26, on responses of isolated rat atria to isoprenaline and noradrenaline.
    Johansson B
    Eur J Pharmacol; 1973 Nov; 24(2):194-204. PubMed ID: 4148794
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacology of practolol, a cardioselective beta adrenergic blocking drug.
    Fitzgerald JD
    Acta Cardiol; 1972; Suppl 16():1-18. PubMed ID: 4405742
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of relative actions of beta-adrenergic blocking drugs on heart rate and left ventricular ejection using a non-invasive method in patients with aortic Starr-Edwards prostheses.
    Crouchman MR
    Br Heart J; 1973 May; 35(5):475-9. PubMed ID: 4146054
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of M&B 17,803A in animals and man.
    Basil B; Collins RF; Cuthbert MF
    Br J Pharmacol; 1973 Mar; 47(3):620P. PubMed ID: 4147192
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenergic antagonists, and a possible link between the increase in cyclic adenosine 3',5'-monophosphate and DNA synthesis during liver regeneration.
    MacManus JP; Braceland BM; Youdale T; Whitfield JF
    J Cell Physiol; 1973 Oct; 82(2):157-64. PubMed ID: 4148138
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of beta-blocking agents.
    Goldstein RE
    Circulation; 1973 Mar; 47(3):443-5. PubMed ID: 4144218
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
    Farmer JB; Kennedy I; Levy GP; Marshall RJ
    Br J Pharmacol; 1972 Aug; 45(4):660-75. PubMed ID: 4404413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of beta-adrenergic blocking activity of DCI, H56-28, ICI50172, LB46, methoxamine, MJ1999 and propranolol in the blood perfused canine papillary muscle preparation.
    Hashimoto K; Endoh M; Tamura K; Taira N
    Experientia; 1970; 26(7):757-9. PubMed ID: 4393455
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation.
    Lucchesi BR; Hodgeman RJ
    J Pharmacol Exp Ther; 1971 Jan; 176(1):200-11. PubMed ID: 4398216
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct and beta-adrenoreceptor blocking effects of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB-46) on myocardial hemodynamics.
    Laddu AR; Somani P
    Arch Int Pharmacodyn Ther; 1972 Mar; 196(1):5-15. PubMed ID: 4400602
    [No Abstract]   [Full Text] [Related]  

  • 19. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK; Hardman HF
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular effects of sustained norepinephrine infusions in dogs. IV. Previous treatment with adrenergic blocking agents.
    Moss AJ; Schenk EA
    Circ Res; 1970 Dec; 27(6):1013-22. PubMed ID: 4395090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.